Metro International Biotech, Llc

This early-stage study is testing a new drug, MIB-725, in 32 healthy adults to see if it is safe and how the body handles it. Participants receive a single dose (ranging from 100 to 800 mg) and are monitored for side effects, changes in vital signs, and lab results over 28 days. …